Metadherin in Metastasis and Chemoresistance of Breast Cancer
美粘素在乳腺癌转移和化疗耐药中的作用
基本信息
- 批准号:7694278
- 负责人:
- 金额:$ 32.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2013-08-31
- 项目状态:已结题
- 来源:
- 关键词:8q22AccountingAddressAdhesionsAdverse effectsAnimal ModelAnimalsBinding ProteinsBiochemicalBiological AssayBreast Cancer CellCancer BiologyCancer PatientCell AdhesionCell LineCessation of lifeCoculture TechniquesComplexDevelopmentDistantEndothelial CellsEndotheliumEngineeringEventGene ExpressionGenesGeneticGenomicsGoalsIn VitroKnockout MiceLungMalignant Epithelial CellMalignant NeoplasmsMammary NeoplasmsMammary glandMediatingMediator of activation proteinMethodsModelingMolecularMolecular TargetNeoplasm MetastasisNormal tissue morphologyNude MiceOncogenesOrganPhysiologicalPlayProcessProteinsRNA InterferenceRecurrent tumorRelapseResearchResistanceRoleSeriesSignal TransductionSpecimenStressSurfaceTestingTherapeuticTherapeutic InterventionTissuesTransgenic AnimalsTransgenic OrganismsVascular Endothelial CellVascular Endotheliumbasecancer cellchemotherapeutic agentchemotherapyhigh riskin vitro Assayin vivoinsightknockout animalmalignant breast neoplasmmammary gland developmentmouse metadherinmouse modelneoplastic cellneutralizing monoclonal antibodiesnoveloutcome forecastoverexpressionpreventpublic health relevancetumortumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Metadherin in Metastasis and Chemoresistance of Breast Cancer Summary: Most breast cancer patients succumb to recurrent tumors that spread to distant vital organs and resist currently available therapeutic regiments. Recent studies have identified Metadherin (MTDH) as a candidate metastasis gene that plays a dual role in promoting breast cancer metastasis and chemoresistance. Our proposed study is based on the following preliminary observations: 1) MTDH is located at the epicenter of 8q22, a genomic region that is frequently amplified in poor-prognosis breast cancer patients; 2) MTDH overexpression is detected in over 40% of breast tumor speciemens, and is strongly correlated with poor survival and higher risk of metastasis for breast cancer patients; 3) MTDH overexpression promotes metastastasis to lung and other organs in an experimental metastasis model. Conversely, inhibition of MTDH expression by RNA interference reduces lung metastasis; 4) MTDH promotes adhesion of breast tumor cells to vascular endothelial cells in vitro and increases metastatic seeding efficiency in animal metastasis assays; 5) MTDH enhances chemoresistance of breast cancer cells to a broad spectrum chemotherapeutic agents as well as other physiological stresses. MTDH-mediated chemoresistance is most pronouced when cancer cells are co-cultured with endothelial cells. Based on these preliminary observations, we postulate that the pro-metastasis and chemoresistance functions of MTDH are mediated through its interaction with unknown interacting protein(s) expressed by endothelial cells. Such interaction activates downstream signaling events and alters gene expression in both tumor and endothelial cells. Blocking the interaction between MTDH and its interacting proteins will inhibit metastasis and sensitize tumor cells to chemotherapies. The long-term goals of our research are to elucidate the molecular mechanisms of breast cancer metastasis and chemoresistance mediated by MTDH and explore the therapeutic applications of inhibiting MTDH function. To this end, we will use genetic and biochemical approaches to identify and characterize MTDH-interacting proteins that mediate tumor-endothelium interaction and explore the potential benefit of inhibiting such interaction (Aim1). We will define the molecular mechanism of MTDH induced chemoresistance and determine the therapeutic potential of MTDH targeting using experimental tumorigenesis and metastasis models (Aim2). Furthermore, we will generate transgenic and knockout mice for MTDH and test the effect of altered MTDH expression on tumorigenesis and metastasis in transgenic animals that are genetically prone to developing mammary tumors. Transgenic and knockout animals of MTDH will also allow us to directly address the physiological role of MTDH in development and mammary gland function (Aim3). The proposed study will identify key components of the molecular network that mediate the metastasis and chemoresistance functions of MTDH and provide new strategies to prevent or reduce chemoresistant metastasis of breast cancer. Metadherin in Metastasis and Chemoresistance of Breast Cancer. PUBLIC HEALTH RELEVANCE: Over 90% of breast cancer related deaths are due to inoperable relapsed tumors in distant vital organs that resist conventional chemotherapies. Our proposed studies will provide novel insights into the molecular mechanism of Metadherin in metastasis and chemoresistance. Furthermore, our research will facilitate the development of anti-metastasis therapeutics based on molecular targeting of Metadherin.
描述(由申请人提供):Metadherin在乳腺癌的转移和化疗耐药性中的作用概述:大多数乳腺癌患者死于复发性肿瘤,这些肿瘤扩散到远处的重要器官并抵抗目前可用的治疗方案。最近的研究发现,Metadherin(MTDH)是一个在促进乳腺癌转移和化疗耐药中起双重作用的候选转移基因。我们的研究基于以下初步观察:1)MTDH位于8 q22的中心,这是一个在预后不良的乳腺癌患者中经常扩增的基因组区域; 2)MTDH过表达在超过40%的乳腺肿瘤标本中被检测到,并且与乳腺癌患者的不良生存和较高的转移风险密切相关; 3)在实验转移模型中,MTDH过表达促进向肺和其他器官的转移。相反,通过RNA干扰抑制MTDH表达减少肺转移; 4)MTDH在体外促进乳腺肿瘤细胞与血管内皮细胞的粘附,并在动物转移测定中增加转移接种效率; 5)MTDH增强乳腺癌细胞对广谱化疗剂以及其他生理应激的化学抗性。当癌细胞与内皮细胞共培养时,MTDH介导的化疗耐药性最明显。基于这些初步观察,我们假设MTDH的促转移和化学抗性功能是通过其与内皮细胞表达的未知相互作用蛋白的相互作用介导的。这种相互作用激活下游信号传导事件并改变肿瘤和内皮细胞中的基因表达。阻断MTDH与其相互作用蛋白之间的相互作用将抑制转移并使肿瘤细胞对化疗敏感。我们的长期研究目标是阐明MTDH介导的乳腺癌转移和化疗耐药的分子机制,并探索抑制MTDH功能的治疗应用。为此,我们将使用遗传和生物化学方法来鉴定和表征介导肿瘤-内皮相互作用的MTDH相互作用蛋白,并探索抑制这种相互作用的潜在益处(Aim 1)。我们将定义MTDH诱导的化学抗性的分子机制,并使用实验性肿瘤发生和转移模型(Aim 2)确定MTDH靶向的治疗潜力。此外,我们将产生MTDH的转基因和基因敲除小鼠,并测试改变MTDH表达对转基因动物中的肿瘤发生和转移的影响,这些转基因动物在遗传上易于发生乳腺肿瘤。MTDH的转基因和敲除动物也将使我们能够直接解决MTDH在发育和乳腺功能中的生理作用(Aim 3)。这项拟议的研究将确定介导MTDH转移和化疗耐药功能的分子网络的关键组成部分,并提供预防或减少乳腺癌化疗耐药转移的新策略。Metadherin在乳腺癌转移和化疗耐药中的作用。公共卫生关系:超过90%的乳腺癌相关死亡是由于远处重要器官中的不可手术复发肿瘤抵抗常规化疗。我们的研究将为Metadherin在肿瘤转移和化疗耐药中的分子机制提供新的见解。此外,我们的研究将促进基于Metadherin分子靶向的抗转移治疗的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yibin Kang其他文献
Yibin Kang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yibin Kang', 18)}}的其他基金
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
癌症代谢和肿瘤宿主相互作用博士后培训项目
- 批准号:
10596510 - 财政年份:2021
- 资助金额:
$ 32.93万 - 项目类别:
Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions
癌症代谢和肿瘤宿主相互作用博士后培训项目
- 批准号:
10375556 - 财政年份:2021
- 资助金额:
$ 32.93万 - 项目类别:
Jagged1-dependent tumor-stromal interactions in bone metastasis
骨转移中Jagged1依赖性肿瘤-基质相互作用
- 批准号:
10064995 - 财政年份:2017
- 资助金额:
$ 32.93万 - 项目类别:
Jagged1-dependent tumor-stromal interactions in bone metastasis
骨转移中Jagged1依赖性肿瘤-基质相互作用
- 批准号:
9218934 - 财政年份:2017
- 资助金额:
$ 32.93万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8054922 - 财政年份:2010
- 资助金额:
$ 32.93万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8607149 - 财政年份:2010
- 资助金额:
$ 32.93万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8447363 - 财政年份:2010
- 资助金额:
$ 32.93万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
7899330 - 财政年份:2010
- 资助金额:
$ 32.93万 - 项目类别:
The Role of miRNAs in Epithelial-Mesenchymal Transition and Metastasis
miRNA 在上皮-间质转化和转移中的作用
- 批准号:
8264374 - 财政年份:2010
- 资助金额:
$ 32.93万 - 项目类别:
Metadherin in Metastasis and Chemoresistance of Breast Cancer
美粘素在乳腺癌转移和化疗耐药中的作用
- 批准号:
8127696 - 财政年份:2008
- 资助金额:
$ 32.93万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 32.93万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Standard Grant
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 32.93万 - 项目类别: